Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation.
The vascular endothelial growth factor receptor, Flt1 is a transmembrane receptor co-expressed with an alternate transcript encoding a secreted form, sFlt1, that functions as a competitive inhibitor of Flt1. Despite shared transcription start sites and upstream regulatory elements, sFlt1 is in far greater excess of Flt1 in the human placenta. Phorbol myristic acid and dimethyloxalylglycine differentially stimulate sFlt1 compared to Flt1 expression in vascular endothelial cells and in cytotrophoblasts. An FLT1 minigene construct containing exon 13, 14 and the intervening region, recapitulates mRNA processing when transfected into COS-7, with chimeric intronic sFlt1 transcripts arising by intronic polyadenylation and other Flt1/sFlt1 transcripts by alternate splicing. Inclusion of exon 15 but not 14 had a modest stimulatory effect on the abundance of sFlt1. The intronic region containing the distal poly(A) signal sequences, when transferred to a heterologous minigene construct, inhibited splicing but only when cloned in sense orientation, consistent with the presence of a directional cis-element. Serial deletional and targeted mutational analysis of cis-elements within intron 13 identified intronic poly(A) signal sequences and adjacent cis-elements as the principal determinants of the relative ratio of intronic sFlt1 and spliced Flt1. We conclude that intronic signals reciprocally regulate splicing and polyadenylation and control sFlt1 expression.
Thomas
Christie P
CP
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USA. christie-thomas@uiowa.edu
Raikwar
Nandita S
NS
Kelley
Elizabeth A
EA
Liu
Kang Z
KZ
D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D019556:COS Cells; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D017124:Conserved Sequence; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism; D006801:Humans; D007438:Introns; D026723:Polyadenylation; D038621:Regulatory Sequences, Ribonucleic Acid; D014327:Trophoblasts / Q000378:metabolism; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000235:genetics* / Q000378:metabolism
D038621:Regulatory Sequences, Ribonucleic Acid; D040281:Vascular Endothelial Growth Factor Receptor-1
FASEB J. 2007 Dec;21(14):3885-95
17615362
Cardiovasc Res. 2005 Feb 15;65(3):550-63
15664381
Genome Res. 2007 Feb;17(2):156-65
17210931
Circ Res. 2008 Jun 20;102(12):1566-74
18515749
Genome Biol. 2005;6(12):R100
16356263
Nucleic Acids Res. 1997 Jul 1;25(13):2547-61
9185563
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705-9
8248162
Dev Cell. 2009 Sep;17(3):377-86
19758562
J Clin Endocrinol Metab. 2003 Nov;88(11):5555-63
14602804
Circ Res. 2004 Oct 29;95(9):884-91
15472115
J Clin Invest. 2003 Mar;111(5):649-58
12618519
J Biol Chem. 1999 Apr 30;274(18):12431-7
10212217
Am J Pathol. 2002 Apr;160(4):1405-23
11943725
Nature. 2008 Nov 27;456(7221):470-6
18978772
Biochem Biophys Res Commun. 2008 Oct 24;375(3):287-91
18680722
Trends Biochem Sci. 2003 Sep;28(9):488-94
13678960
Nucleic Acids Res. 2005 Jan 12;33(1):201-12
15647503
Am J Obstet Gynecol. 1999 Apr;180(4):896-902
10203658
Placenta. 2009 Mar;30(3):250-5
19147226
Nature. 2006 Oct 26;443(7114):993-7
17051153
J Biol Chem. 2003 Apr 11;278(15):12605-8
12538598
Hypertension. 2009 Nov;54(5):1129-35
19786649
J Clin Endocrinol Metab. 2009 Jul;94(7):2524-30
19336504
Gene. 1998 Feb 27;208(2):297-305
9524283